Who we are

ICP Faculty, our approach and contact information

ICP Faculty
Richard Sullivan
Director, ICP

Richard Sullivan is Professor, Cancer Policy & Global Health at Kings College London and Director of the new Kings Institute of Cancer Policy. As a member of the Integrated Cancer Centre executive he leads the international strategy and is also Visiting Professor at the Faculty of Medicine, Universidad Catolica, Chile, and Washington University. Richard also serves on Kings Centre for Global Health and the Marjan Centre for Conflict & Conservation.

Arnie Purushotham
Chair, ICP Scientific Board

Arnie Purushotham is Professor of Breast Cancer at King’s College London and Honorary Consultant Surgeon at Guy’s and St Thomas’ NHS Foundation Trust. His roles include Director of the Integrated Cancer Centre and Clinical Academic Lead for Cancer at King’s Health Partners. He is also the Clinical Director for the London Cancer Alliance.

Henrik Møller

Henrik Møller is Professor of Cancer Epidemiology at King’s College London School of Medicine, and Director of Cancer Epidemiology and Population Health in King’s Health Partners Integrated Cancer Centre. He was a Director at the Thames Cancer Registry from 2000 to 2011.

Dr Grant Lewison

Dr Grant Lewison was originally trained as a mechanical engineer at Cambridge. He has been working in science policy and research evaluation since 1981. He has specialised in bibliometrics (the quantitative study of publications) since 1993 when he joined the Wellcome Trust to set up and run the Research Outputs Database (ROD) as a “club” project with around 30 members.

Ajay Aggarwal

Dr Ajay Aggarwal is a Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Trust and Honorary Senior Lecturer at King’s College London in the Department of Cancer Epidemiology, Population and Global Health.

Kalipso Chalkidou

Kalipso Chalkidou is the founding director of NICE’s international programme, helping governments build technical and institutional capacity for using evidence to inform health policy. She is interested in how local information, local expertise and local institutions can drive scientific and legitimate healthcare resource allocation decisions.

Stuart Hogarth

Dr Stuart Hogarth is a member of the Department of Social Science, Health and Medicine at King’s College London. He trained in the history of medicine, but now works at the interface between medical sociology, bioethics and science and technology studies.

Julia Fan Li

Julia Fan Li is a Director at Lion’s Head Global Partners with primary responsibility for the Global Health Investment Fund (GHIF). The GHIF aims to fund research and development of global health interventions including drugs, vaccines and diagnostics for diseases that disproportionately burden low-income countries.

Gemma Derrick

Gemma is currently an ESRC Future Research Leader Fellow with the Health Economics Research Group at Brunel University. She graduated from a PhD in Science Communication and Research Evaluation from The Australian National University in 2010.

Tim Eden

Tim Eden has held Consultant jobs in Bristol, Edinburgh, London and Manchester, the latter two as Professor of Oncology, initially in Paediatrics but latterly as the Teenage Cancer Trust Professor of Teenage and Young Adult Cancer. He us now Emeritus Professor in Paediatric and Adolescent Oncology at Manchester University.

Robert Thomas

Bob Thomas graduated from Medicine from the University of Melbourne and trained in surgery at the Royal Melbourne Hospital as well as in England and Boston. He commenced surgical practice at the Royal Melbourne Hospital where he also taught medical students.

Fran Woodard

As Director of England for Macmillan Cancer Support, Fran leads a Directorate of over 100 people delivering service development and innovation, specifically with a focus on whole system redesign to deliver joined up, seamless pathways of care for cancer patients across England.

Rajendra Badwe

Dr RA Badwe has more than 25 years diverse experience as a Surgeon and Oncologist, and as Director, has led Tata Memorial Centre, a world renowned institution in the field of cancer care.

Ophira Ginsburg

Ophira Ginsburg is a medical oncologist with a primary focus in women’s health equity and global cancer control. She is a fellow of the Royal College of Physicians and Surgeons (Canada), a Scientist at Women’s College Research Institute, and holds academic appointments at the University of Toronto, and James P Grant School of Public Health, BRAC University, Bangladesh. She is an advisor to the National Institute for Cancer Control of Vietnam, a member of the Technical Advisory Committee of the Harvard-based GTF.CCC and recently joined the first Global Task Force on Radiotherapy for Cancer Control.

Mohandas Mallath

Mohandas Mallath is currently the senior consultant in department of digestive diseases at the Tata Medical Center, Kolkata. His current appointments includes: Member, Academic Council, Medical Council of India, and Member, Digestive Oncology Taskforce, World Gastroenterology Organization.

Alexander Eggermont

Alexander Eggermont is the Director General of the Gustave Roussy CCC, Villejuif/Paris-Sud, He is Full Professor of Oncology (Classe Exceptionnelle) at the Paris-Sud University in Paris, France. He is Full Professor of Surgical Oncology as well as Endowed Professor of International Networking in Cancer Research at the Erasmus University Medical Centre in Rotterdam.

Gabriella Pravettoni

Gabriella Pravettoni is full professor of Cognitive Psychology at the Department of Health Sciences, University of Milan, Director of the Interdisciplinary Research Center on Decision Making Processes (IRIDe) and Director of the Applied Research Unit for Cognitive and Psychological Science at the European Institute of Oncology (IEO) in Milan.

Elena Pallari

Elena Pallari is Research Assistant at King’s College London School of Medicine. Her current work is on the evaluation of the research impact of Europe in 5 NCD (non-communicable disease) areas. Previously she has held posts at the Brunel Institute for Bioengineering and Imperial College Business School working on the conduct and evaluation of RCTs (randomised controlled trials).

Jean-Marc Bourque

Dr. Jean-Marc Bourque studied medicine at l’Université de Montréal and radiation oncology at Western University, while also completing a 2-year Global Health Certificate at the Dalla Lana School of Public Health at the University of Toronto.

The Institute of Cancer Policy studies and provides policy solutions to some of the world’s most important cancer public policy issues. It was founded out of the European Cancer Research Managers Foundation with a 10-year history of delivering high impact public policy research in cancer.

As well as high impact publications on research funding & activity, cancer drug development, surgery, mental health and cancer, to name but a few areas, we have also led major global cancer policy reports , for example major Lancet Oncology Commissions on:

This research has been extensively reported on in the international media and used by organisations such as the American Cancer Society in its Global Cancer Atlas.

The ICP has also been a key policy partner for many major national and international programs ranging from EUROCAN + (pan European project to co-ordinate cancer R&D), and EUROCANCERCOMS (developing new cancer information approaches for the community) to political leadership in the European Union in clinical trials regulations (with the European Science Foundation) and R&D (Slovenian Commission Presidency) and the development of European cancer translational R&D (EUROCANPLATFORM).

Globally we work with specific countries and organisations to provide bespoke market intelligence, strategic consultancy and high impact academic policy research into key cancer policy issues.

Our Approach

The Institute of Cancer Policy is strategically aligned with cancer’s leading educational open access journal ecancer which provides the key e-dissemination and education routes for high impact cancer policy. This also allows the ICP to provide educational solutions for the cancer community, be they patients, researchers or healthcare professionals. In addition we work with a broad range of partners both within Kings Health Partners, particularly Social Science, Health and Medicine, Kings Centre for Global Health, NICE (International) and outside, e.g. Health Economics Research Centre, Oxford and the CIBER group. In addition to the strengths that these partners bring to the transdisciplinary research nature of cancer policy the ICP is also an integral and embedded part of Kings Health Partners Integrated Cancer Centre.

The ICP also has access to a wide range of global cancer key opinion leaders in both high and emerging economies, e.g. Tata Memorial Centre, Mumbai and Universidad Catolica Cancer Centre, Santiago. These strategic partnerships with major cancer centres allow us to ‘deep dive’ policy research to ensure its validity in the real world.